Share chart Wockhardt Limited
Extended chart
Simple chart
About Wockhardt Limited
Wockhardt Limited, фармацевтическая и биотехнологическая компания, производит и продает активные фармацевтические ингредиенты, составы, биоаналоги и вакцины в Индии, США, Великобритании, Ирландии, Мексике, России и за рубежом. Он разрабатывает различные молекулы, прежде всего, в области инфекционных заболеваний, такие как молекулы WCK 5222, WCK 4282, WCK 4873, WCK 771 и WCK 2349, а также молекулы WCK 6777. more detailsMain settings
ISIN
INE049B01025
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0
Дивиденд ао
9.22
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 2.99 | 6 |
| P/BV | 2.28 | 6 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -6.04 | 0 |
| ROE | -13.79 | 0 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.7143 | 7.14 |
| Average dividend growth | -16.89 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -29.75 | 10 |
| Debt/Ratio | 0.2761 | 10 |
| Debt/Equity | 1.09 | 8 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | -1.55 | 0 |
| Yield Ebitda, % | -156.43 | 0 |
| Yield EPS, % | 422.06 | 10 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 1 334.2 ₹ | 0 ₹ | 0 ₹ | 0.83 % | 0 % | 0.55 % |
| Week | 1 325 ₹ | 0 ₹ | 0 ₹ | 1.53 % | 0 % | -0.23 % |
| Month | 1 396.35 ₹ | 1 227.95 ₹ | 1 359.35 ₹ | -3.66 % | 0 % | 0.99 % |
| Three month | 1 229.4 ₹ | 1 199.5 ₹ | 1 516.25 ₹ | 9.42 % | 0 % | 9.55 % |
| Half a year | 1 346.15 ₹ | 1 158.65 ₹ | 1 651.8 ₹ | -0.07 % | 0 % | -0.08 % |
| Year | 560.7 ₹ | 565.4 ₹ | 1 651.8 ₹ | 139.92 % | 0 % | 9.49 % |
| 3 years | 258.3 ₹ | 149.6 ₹ | 1 651.8 ₹ | 420.81 % | 0 % | 42.94 % |
| 5 years | 265.85 ₹ | 149.6 ₹ | 1 651.8 ₹ | 406.02 % | 0 % | 0 % |
| 10 years | 0 ₹ | 149.6 ₹ | 1 724.6 ₹ | 0 % | 0 % | 0 % |
| Year to date | 1 453.8 ₹ | 1 158.65 ₹ | 1 651.8 ₹ | -7.47 % | 0 % | 4.23 % |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Habil Fakhruddin Khorakiwala | Founder & Executive Chairman | 29M | 1941 (84 years) |
| Dr. Murtaza Habil Khorakiwala | MD & Executive Director | 24M | 1973 (52 years) |
| Dr. Huzaifa Habil Khorakiwala | Executive Director | 24M | 1971 (54 years) |
| Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA | Senior Vice President of Business Development | N/A | 1951 (74 years) |
| Mr. Zoher T. Sihorwala | Head of Global Regulatory Affairs | N/A | 1970 (55 years) |
| Mr. Prakash Gupta | President of Supply Chain | N/A | |
| Mr. Neeraj Agarwal | Chief Human Resource Officer | N/A | |
| Ms. Debolina Partap | Senior Vice President of Legal | N/A | |
| Mr. Deepak R. Madnani | Chief Financial Officer | ||
| Dr. Mahesh Vithalbhai Patel | Chief Scientific Officer of New Drug Discovery |
About company
Address: India, Mumbai, Wockhardt Towers - Open in google maps, Open in yandex maps
Website: https://www.wockhardt.com
Website: https://www.wockhardt.com
